Visikol Becomes VIP Supplier on Scientist.com Marketplace
Mike Johnson2020-11-05T10:48:01-05:00Visikol, a leading drug discovery company focused on advanced imaging, digital pathology and 3D cell culture assays, announced today [...]
Visikol, a leading drug discovery company focused on advanced imaging, digital pathology and 3D cell culture assays, announced today [...]
3D cell culture models (e.g. organoids, spheroids, micro-tissues) provide researchers with the ability to better mimic the in vivo [...]
In this webinar, we’ve partnered with Molecular Devices and Corning to present a case study for integrating novel [...]
Visikol is a leading provider of advanced cell culture assays and has recently been expanding its portfolio of in [...]
Cellular migration plays an integral role in the development and maintenance of many biological processes present in multicellular organisms. [...]
Interested to learn more about how Visikol is enabling cutting edge organoid research? In this publication, the Visikol HISTO-M [...]
Liver disease affects millions of people in the United States alone, resulting in tens of thousands of deaths yearly, [...]
Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues [...]
The liver is a tantalizing organ to model because of its role in drug metabolism and as a target [...]
Immunohistochemistry has been routinely used to study the cellular and sub-cellular distribution of proteins; however, traditional staining methods are [...]